Literature DB >> 17950742

Ethnic differences between extra-coronary measures on cardiac computed tomography: multi-ethnic study of atherosclerosis (MESA).

Khurram Nasir1, Ronit Katz, Junichiro Takasu, David M Shavelle, Robert Detrano, Joao A Lima, Roger S Blumenthal, Kevin O'Brien, Matthew J Budoff.   

Abstract

BACKGROUND: Emerging evidence indicates that calcifications in valvular and thoracic aorta are manifestations of generalized atherosclerosis. Assessing the presence and extent of extra-coronary atherosclerosis may further improve prognostic information in subjects who are at risk for cardiovascular disease. The aim of the study is to determine the relative prevalence and quantity of extra-coronary calcifications across ethnic groups in a multi-ethnic population based cohort of asymptomatic individuals. METHODS AND
RESULTS: The ethnic differences associated with aortic valve calcification (AVC), mitral valve calcification (MVC), aortic valve root calcification (AVRC) and thoracic aortic wall calcification (TAC) were assessed in 6814 asymptomatic individuals in the multi-ethnic study of atherosclerosis (MESA) study. The overall prevalence of AVC, MVC, AVRC and TAC was 13, 10, 34 and 28%, respectively). As far as the valvular calcifications (AVC, MVC, AVRC) are concerned, the highest prevalence was observed in the Whites, followed by Hispanics and African-Americans with the lowest levels of calcification among the Chinese (all p<0.001). On the other hand, the Chinese along with Whites had the highest prevalence of TAC (p<0.001). After adjustment for traditional CVD risk factors and coronary artery calcification, the relative risk of AVC compared with Whites was 0.72 in Blacks (95% CI 0.59-0.90), 1.03 in Hispanics (95% CI 0.82-1.28) and 0.56 in Chinese (95% CI 0.40-0.80). Similar associations were observed for the presence of MVC and AVRC. However, as compared to Whites, the relative risk for presence of TAC was not significantly lower among Hispanics (RR: 0.83, 95% CI: 0.68-1.01) and Chinese Americans (RR: 1.24, 95% CI: 0.95-0.1.62); however Blacks had a significantly lower risk of TAC (RR: 0.50, 95% CI: 0.41-0.60), respectively.
CONCLUSIONS: Racial differences exist in the prevalence of extra-coronary calcification in a large multi-ethnic population of asymptomatic individuals, thus underscoring the need for developing population specific nomograms to identify overall atherosclerotic burden in a more accurate manner in different ethnic groups. Further studies are needed to assess prognostic potential of each of these new measures of extra-coronary calcification in predicting subsequent cardiovascular events, independently and incrementally above known cardiovascular risk factors and the amount of calcified coronary plaque.

Entities:  

Mesh:

Year:  2007        PMID: 17950742     DOI: 10.1016/j.atherosclerosis.2007.09.008

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  35 in total

1.  Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Somsupha Kanjanauthai; Khurram Nasir; Ronit Katz; Juan J Rivera; Junichiro Takasu; Roger S Blumenthal; John Eng; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2010-09-16       Impact factor: 5.162

2.  The impact of gender on cardiovascular system calcification in very elderly patients with severe aortic stenosis.

Authors:  Luckmini Liyanage; Nam Ju Lee; Tessa Cook; Howard C Herrmann; Dinesh Jagasia; Harold Litt; Yuchi Han
Journal:  Int J Cardiovasc Imaging       Date:  2015-08-29       Impact factor: 2.357

3.  Spatiotemporal Multi-Omics-Derived Atlas of Calcific Aortic Valve Disease.

Authors:  Aldrin V Gomes
Journal:  Circulation       Date:  2018-07-24       Impact factor: 29.690

Review 4.  Biomarkers of Calcific Aortic Valve Disease.

Authors:  Aeron Small; Daniel Kiss; Jay Giri; Saif Anwaruddin; Hasan Siddiqi; Marie Guerraty; Julio A Chirinos; Giovanni Ferrari; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-02-02       Impact factor: 8.311

5.  Risk factors associated with the incidence and progression of mitral annulus calcification: the multi-ethnic study of atherosclerosis.

Authors:  Sammy Elmariah; Matthew J Budoff; Joseph A C Delaney; Yasmin Hamirani; John Eng; Valentin Fuster; Richard A Kronmal; Jonathan L Halperin; Kevin D O'Brien
Journal:  Am Heart J       Date:  2013-09-26       Impact factor: 4.749

6.  Racial differences in the association between carotid plaque and aortic and coronary artery calcification among women transitioning through menopause.

Authors:  Genevieve A Woodard; Vinod V Narla; Rong Ye; Jane A Cauley; Trina Thompson; Karen A Matthews; Kim Sutton-Tyrrell
Journal:  Menopause       Date:  2012-02       Impact factor: 2.953

Review 7.  Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease.

Authors:  Katherine E Yutzey; Linda L Demer; Simon C Body; Gordon S Huggins; Dwight A Towler; Cecilia M Giachelli; Marion A Hofmann-Bowman; Douglas P Mortlock; Melissa B Rogers; Mehran M Sadeghi; Elena Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09-04       Impact factor: 8.311

8.  Cardiovascular risk factors and mitral annular calcification in type 2 diabetes.

Authors:  Atif N Qasim; Hashmi Rafeek; Suraj P Rasania; Timothy W Churchill; Wei Yang; Victor A Ferrari; Saurabh Jha; Stephen M Master; Claire K Mulvey; Karen Terembula; Chris Dailing; Matthew J Budoff; Steven M Kawut; Muredach P Reilly
Journal:  Atherosclerosis       Date:  2012-12-05       Impact factor: 5.162

9.  The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus.

Authors:  Azza Farrag; Sameh Bakhoum; Mohammed Ali Salem; Amr El-Faramawy; Emmanuel Gergis
Journal:  Heart Vessels       Date:  2011-11-03       Impact factor: 2.037

10.  Atherosclerosis profile and incidence of cardiovascular events: a population-based survey.

Authors:  Jennifer G Robinson; Kathleen M Fox; Michael F Bullano; Susan Grandy
Journal:  BMC Cardiovasc Disord       Date:  2009-09-15       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.